TOMI Environmental Solutions Secures Two New Purchase Agreements with Leading Pharmaceutical Companies
10 Junho 2024 - 10:00AM
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a
global company specializing in disinfection and decontamination
utilizing its premier Binary Ionization Technology (BIT) platform
through its SteraMist brand of products, is pleased to announce two
recent sales in the Life Sciences sector, underscoring the
Company’s successful strategic expansion in the sector and growth
potential.
The first purchase agreement, signed with one of the largest
private pharmaceutical companies in the world, includes the
acquisition of a SteraMist Environment System and TOMI validation
services for the client’s vivarium facility in Mexico. This
landmark contract strengthens TOMI’s long-standing relationship
with the company in the United States and expands TOMI’s footprint
in its global operations, highlighting the Company’s ability to
scale and support international partners.
The second purchase agreement arises from the Company’s
collaboration with a trusted partner with decades of experience in
big pharma. This partnership facilitated the sale of the first
Hybrid System to Indigo Pharmaceutical, Inc. as announced in
September 2023. Continuing this momentum, the partner has now
successfully sold another SteraMist Hybrid System to BeSpoke
Pharmaceuticals, a Nevada-based manufacturer targeting 503B
products. This advanced turnkey custom installation, valued at over
$200,000, exemplifies TOMI’s innovative solutions and expanding
market reach.
“These two wins represent the significant progress TOMI is
making in expanding our reach and capabilities within the
pharmaceutical industry, reinforcing the Company’s potential for
long-term growth,” said Elissa J. (E.J.) Shane, Chief Operating
Officer of TOMI. “Building and expanding our presence within these
large companies is a strategic priority for the Company. With the
broad array of product offerings we provide, we are confident in
our ability to meet and exceed our customers' needs. Furthermore,
the partnerships we have cultivated, including consultants,
designers, and contractors for new facilities around the world, are
critical to this expansion. These relationships and our business
development strategies now firmly position us for future success.
We look forward to continuing to leverage our superior technology
and industry relationships to drive increased market penetration in
the rapidly evolving Life Sciences sector.”
TOMI™ Environmental Solutions, Inc.: Innovating for
a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a
global decontamination and infection prevention company, providing
environmental solutions for indoor surface disinfection through the
manufacturing, sales and licensing of its premier Binary Ionization
Technology® (BIT™) platform. Invented under a defense grant in
association with the Defense Advanced Research Projects Agency
(DARPA) of the U.S. Department of Defense, BIT™ solution
utilizes a low percentage Hydrogen Peroxide as its only active
ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™).
Represented by the SteraMist® brand of products,
iHP™ produces a germ-killing aerosol that works like a visual
non-caustic gas.
TOMI products are designed to service a broad spectrum of
commercial structures, including, but not limited to, hospitals and
medical facilities, cruise ships, office buildings, hotel and motel
rooms, schools, restaurants, meat and produce processing
facilities, military barracks, police and fire departments, and
athletic facilities. TOMI products and services have also
been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols
for its clients and is a member in good standing with The American
Biological Safety Association, The American Association of Tissue
Banks, Association for Professionals in Infection Control and
Epidemiology, Society for Healthcare Epidemiology of America,
America Seed Trade Association, and The Restoration Industry
Association.
For additional information, please
visit https://www.steramist.com/ or contact us
at info@tomimist.com.
Forward-Looking Statements
This press release contain forward-looking statements that are
based on current expectations, estimates, forecasts and projections
of future performance based on management’s judgment, beliefs,
current trends, and anticipated product performance. These
forward-looking statements include, without limitation, statements
relating to cost reduction measures and compensation changes;
anticipated launch of new products; expected growth in sales
pipeline and market demand; revenue opportunities of CES products
and brand recognition of our products. Forward-looking statements
involve risks and uncertainties that may cause actual results to
differ materially from those contained in the forward-looking
statements. These factors include, but are not limited to, our
ability to acquire new customers and expands sales; our ability to
maintain and manage growth and generate sales, our reliance on a
single or a few products for a majority of revenues; the general
business and economic conditions; and other risks as described in
our SEC filings, including our Annual Report on Form 10-K for the
fiscal year ended December 31, 2023 filed by us with the SEC and
other periodic reports we filed with the SEC. The information
provided in this document is based upon the facts and circumstances
known at this time. Other unknown or unpredictable factors or
underlying assumptions subsequently proving to be incorrect could
cause actual results to differ materially from those in the
forward-looking statements. Although we believe that the
expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, level of activity,
performance, or achievements. You should not place undue reliance
on these forward-looking statements. All information provided in
this press release is as of today’s date, unless otherwise stated,
and we undertake no duty to update such information, except as
required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Roz Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
TOMI Environmental Solut... (NASDAQ:TOMZ)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
TOMI Environmental Solut... (NASDAQ:TOMZ)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024